PROPERTIES OF GROWTH-HORMONE AND PROLACTIN HYPERSECRETION BY THE HUMAN INFANT ON THE DAY OF BIRTH

被引:46
作者
DEZEGHER, F
DEVLIEGER, H
VELDHUIS, JD
机构
[1] CATHOLIC UNIV LEUVEN, DEPT PEDIAT, B-3000 LOUVAIN, BELGIUM
[2] UNIV VIRGINIA, DEPT INTERNAL MED, CHARLOTTESVILLE, VA 22908 USA
关键词
D O I
10.1210/jc.76.5.1177
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The neonatal period is the only interval in postnatal life characterized by physiologically elevated plasma concentrations of GH and PRL, two hormones of common origin. To study the secretion of GH and PRL on the day of birth, we obtained at regular intervals (every 20 min for 6 h) blood from seven polycythemic newborns (gestational age 34-41 weeks; birthweight 1600-3960 g, postnatal age 6-23 h) during a therapeutic, standardized, isovolumetric, partial exchange transfusion. Serum GH concentrations were measured by RIA and PRL levels by immunoradiometric assay. Deconvolution analysis of the profiles revealed that all infants displayed a pulsatile pattern of amplified GH release (range 9-191 mug/L). Bursts of GH secretion occurred at a median interval of 73 min. The median serum GH half-life was 18 min. All infants had continuously elevated serum PRL concentrations (range 86-191 mug/L) and none appeared to release PRL episodically. There was no significant cross-correlation between the secretion of GH and PRL. Mean serum GH concentrations during the 6-h study were higher than in cord serum at birth, whereas PRL and insulin-like growth factor-I levels were lower than at birth. In conclusion, the neonatal hypersomatotropism appears to be characterized by high-amplitude, high-frequency, pulsatile secretion of GH without a prolonged GH half-life, whereas hyperprolactinemia seems to result from GH-independent, continuous PRL release. The immediate postnatal rise of GH secretion in the human newborn may be related to decreased inhibition by circulating insulin-like growth factor-1.
引用
收藏
页码:1177 / 1181
页数:5
相关论文
共 37 条
  • [1] HUMAN-FETAL ADENOHYPOPHYSIS - ELECTRON-MICROSCOPIC AND ULTRASTRUCTURAL IMMUNOCYTOCHEMICAL ANALYSIS
    ASA, SL
    KOVACS, K
    HORVATH, E
    LOSINSKI, NE
    LASZLO, FA
    DOMOKOS, I
    HALLIDAY, WC
    [J]. NEUROENDOCRINOLOGY, 1988, 48 (04) : 423 - 431
  • [2] ONTOGENESIS OF HUMAN FETAL HORMONES .4. SOMATOSTATIN, LUTEINIZING-HORMONE RELEASING FACTOR, AND THYROTROPIN RELEASING FACTOR IN HYPOTHALAMUS AND CEREBRAL-CORTEX OF HUMAN FETUSES 10-22 WEEKS OF AGE
    AUBERT, ML
    GRUMBACH, MM
    KAPLAN, SL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 44 (06) : 1130 - 1141
  • [3] AUBERT ML, 1976, J CLIN INVEST, V56, P155
  • [4] DOPAMINE - A PROLACTIN-INHIBITING HORMONE
    BENJONATHAN, N
    [J]. ENDOCRINE REVIEWS, 1985, 6 (04) : 564 - 589
  • [5] TRANSGENIC MICE WITH INDUCIBLE DWARFISM
    BORRELLI, E
    HEYMAN, RA
    ARIAS, C
    SAWCHENKO, PE
    EVANS, RM
    [J]. NATURE, 1989, 339 (6225) : 538 - 541
  • [6] BOUILLON R, 1974, ANN ENDOCRINOL-PARIS, V35, P606
  • [7] CLONING AND EXPRESSION OF THE RAT PROLACTIN RECEPTOR, A MEMBER OF THE GROWTH-HORMONE PROLACTIN RECEPTOR GENE FAMILY
    BOUTIN, JM
    JOLICOEUR, C
    OKAMURA, H
    GAGNON, J
    EDERY, M
    SHIROTA, M
    BANVILLE, D
    DUSANTERFOURT, I
    DJIANE, J
    KELLY, PA
    [J]. CELL, 1988, 53 (01) : 69 - 77
  • [8] ONTOGENY OF THE NEUROGLANDULAR SYSTEM REVEALED WITH HPGRF-44 ANTIBODIES IN HUMAN HYPOTHALAMUS
    BRESSON, JL
    CLAVEQUIN, MC
    FELLMANN, D
    BUGNON, C
    [J]. NEUROENDOCRINOLOGY, 1984, 39 (01) : 68 - 73
  • [9] DEIBER M, 1989, J CLIN ENDOCR METAB, V68, P231
  • [10] DEZEGHER F, 1988, LANCET, V2, P1489